|
|
FDADocs 5/9/2008 | 0 (0) | 23 | 2 | 0 | English
DIVISION OF DRUG ONCOLOGY PRODUCTS Briefing Document for Oncology Drug Advisory Committee NDA: Applicant: Established Drug Name: 21-986, N-000 Bristol-Myers Squibb Dasatinib (BMS-3... ... more>>
sammyc2007 4/23/2008 | 0 (0) | 47 | 2 | 0 | English
The Academic Anesthesia Department and The FDALex Schultheis, M.D., Ph.D.Division of Anesthetic, Analgesic, and Rheumatology Products CDER/FDAThe content of this talk does not necessarily ... more>>
FDADocs 5/5/2008 | 0 (0) | 17 | 2 | 0 | English
Fenwal Automated Devices: FDA Licensing Workshop August 2007Agenda??? ALYX??? ??? ??? ??? Double LR RBCs LR RBCs/Plasma Non-LR Double RBCs (limited launch) Plasma (not in distribution ... more>>
FDADocs 5/9/2008 | 0 (0) | 164 | 2 | 0 | English
Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) with the Advisory Committee for ... more>>
FDADocs 5/9/2008 | 1 (1) | 84 | 2 | 0 | English
DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Rockville, MD 20857September 28, 2006Reference Number: Dear Aripiprazole ANDA Applicant: This letter i... ... more>>
FDADocs 5/8/2008 | 0 (0) | 37 | 2 | 0 | English
L 75/18ENOfficial Journal of the European Communities16.3.2002COMMISSION REGULATION (EC) No 472/2002 amending Regulation (EC) No 466/2001 setting maximum levels for... ... more>>
FDADocs 5/5/2008 | 0 (0) | 13 | 2 | 0 | English
Embryonic Stem Cell-based Therapies: US-FDA Regulatory ExpectationsDonald W. Fink, Jr., Ph.D.Phone: (301) 827-5153 E-Mail: donald.fink@fda.hhs.govOffice of Cellular, Tissue and Gene Therapies ... more>>
FDADocs 5/12/2008 | 0 (0) | 19 | 2 | 0 | English
The Division of Drug Marketing, Advertising, and Communications (DDMAC) protects the public health by assuring prescription drug information is truthful, balanced, and accurately c... ... more>>
FDADocs 5/12/2008 | 0 (0) | 32 | 2 | 0 | English
Hospital Acquired Pneumonia (HAP) Joint FDA/IDSA/PhRMA WorkshopSary Beidas, MD Medical Officer CDER/DSPIDPNovember 20, 2002Definition of HAP (& Diagnosis):???Clinical: Temp, WBC, Sputum ... more>>
FDADocs 5/9/2008 | 0 (0) | 24 | 2 | 0 | English
FDADocs 5/9/2008 | 0 (0) | 33 | 2 | 0 | English
FDADocs 5/12/2008 | 0 (0) | 25 | 2 | 0 | English
SPL DemonstrationJune 4, 2004Who is FCG?Who is FCG?A leading provider of consulting, technology, applied research and outsourcing services to the life sciences and he... ... more>>
FDADocs 5/12/2008 | 0 (0) | 31 | 2 | 0 | English
Antimicrobial Drug Development for Acute Bacterial MeningitisJoint FDA/IDSA/PhRMA WorkshopImo Ibia, MD, MPH Medical Officer FDA/CDER/DSPIDPNovember 20, 2002Office of New Drugs IV Center ... more>>
FDADocs 5/5/2008 | 0 (0) | 46 | 1 | 0 | English
FDA Regulations and Recommendations for Failure InvestigationsHoi-may Wong, BS, MT(ACSP)SBB Blood and Plasma Branch Division of Blood Applications, FDA, CBER, OBRRFDA Workshop Licensure of ... more>>
GovernmentDocs 5/4/2008 | 0 (0) | 113 | 1 | 0 | English
???FDA Regulatory Pathway???2nd Annual FDA and the Changing Paradigm for Tissue Regulation... Regulations that apply Examples of jurisdictional recommendations and decisions ??? Questions and ... more>>
| | | |
| results / page 15/25/50 |
Page: 2 of 33
|
2...
|
|